Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration.

× No keyword cloud information.

46 in total

1. [Update hyperthyreoidism].

Authors: L Möller; K Mann
Journal: Internist (Berl) Date: 2010-05 Impact factor: 0.743

2. Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008.

Authors: Ana B Emiliano; Laura Governale; Mary Parks; David S Cooper
Journal: J Clin Endocrinol Metab Date: 2010-03-24 Impact factor: 5.958

Review 3. Diagnosis and management of Graves disease: a global overview.

Authors: Luigi Bartalena
Journal: Nat Rev Endocrinol Date: 2013-10-15 Impact factor: 43.330

4. A comparison of antineutrophil cytoplasmic antibody prevalence in patients treated and untreated for hyperthyroidism.

Authors: Turan Calhan; Ebubekir Senateş; Egemen Cebeci; Sayid Shafi Zuhur; Fatma Ozbakır; Uğur Görpe
Journal: Endocrine Date: 2010-07-11 Impact factor: 3.633

5. Thyroid gland: Antithyroid therapy--best choice of drug and dose.

Authors: Jayne A Franklyn
Journal: Nat Rev Endocrinol Date: 2009-11 Impact factor: 43.330

6. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum.

Authors: Alex Stagnaro-Green; Marcos Abalovich; Erik Alexander; Fereidoun Azizi; Jorge Mestman; Roberto Negro; Angelita Nixon; Elizabeth N Pearce; Offie P Soldin; Scott Sullivan; Wilmar Wiersinga
Journal: Thyroid Date: 2011-07-25 Impact factor: 6.568

The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration.

1. [Update hyperthyreoidism].

2. Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008.

Review 3. Diagnosis and management of Graves disease: a global overview.

4. A comparison of antineutrophil cytoplasmic antibody prevalence in patients treated and untreated for hyperthyroidism.

5. Thyroid gland: Antithyroid therapy--best choice of drug and dose.

6. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum.

Review 7. Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies.

8. Adverse events associated with methimazole therapy of graves' disease in children.

9. 63 years and 715 days to the "boxed warning": unmasking of the propylthiouracil problem.

10. Embryonic exposure to propylthiouracil disrupts left-right patterning in Xenopus embryos.